Research Article

Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter

Volume: 4 Number: 3 December 31, 2024
EN TR

Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter

Abstract

Objective: This study aimed to evaluate the clinical, radiological, and laboratory risk factors for differentiated thyroid cancers in patients with nodular thyroid disease and to investigate the relationship between these findings and the cytopathological features of the nodules. Materials and Methods: Demographic data, laboratory and imaging findings, and fine-needle aspiration pathology results of 323 patients with incidentally detected thyroid nodules during clinical or radiological examination at the Endocrinology Clinic were retrospectively evaluated and recorded. Results: Fine-needle aspiration biopsy of the dominant nodules revealed that 309 (95.6%) patients had benign nodules, while 14 (4.33%) had malignant nodules. Among patients with benign nodules, microcalcifications were detected in 274 (88.7%) cases, and macrocalcifications were observed in 18 (5.8%). In the malignant group, irregular nodule margins were noted in 1 (7.1%) patient, and multinodular goiter was present in 8 (57.1%). On thyroid ultrasound imaging, 8 (57.1%) patients with malignant nodules exhibited hypoechoic nodules, and 4 (28.6%) displayed microcalcifications. The internal structure of malignant dominant nodules was heterogeneous in 10 (71.4%) cases. Conclusion: This study examined the relationship between histological results and various nodule characteristics, including echogenicity, diameter, calcification type, edge irregularity, autoimmunity, thyroid hormone levels, and cystic content. No significant associations were identified in the analyses, including the presence of microcalcifications (p = 0.074). Broad-spectrum prospective studies with larger patient cohorts are needed to provide further insights and contribute to the existing literature.

Keywords

References

  1. Guth S., Theune U., Aberle J., Galach A., Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009; 39(8):699-706. Doi: 10.1111/j.1365-2362.2009.02162.x.
  2. Pacini F., Schlumberger M., Dralle H., Elisel R., Smit J., Wiersinga W. European consensus for the management of patients with differentisted thyroid carcinoma of the follicular epitelium. Eur J End 2006; 154(6):787-803. Doi:10.1530/eje.1.02158.
  3. Haugen BR., Alexander EK., Bible KC., et al. American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26(1):1-133. Doi:10.1089/thy.2015.0020.
  4. Tan GH., Gharib H. Thyroid incidentalomas management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126(3):226-31. Doi:10.7326/0003-4819-126-3-199702010-00009.
  5. Wang C., Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997; 26(1):189-218. Doi:10.1016/s0889-8529(05)70240-1.
  6. Oyar O. Neck ultrasonography first ed. Izmir: E.U.Basimevi; 2000 .p.85-100.
  7. Haymart MR., Reyes-Gastelum D., Caoili E., Norton EC,. Banerjee M. The relationship between imaging and thyroid cancer diagnosis and survival. The Oncologist 2020; 25(9): 765–771. Doi:10.1634/theoncologist.2020-0159.
  8. Witczak J., Taylor P., Chai J., et al. Predicting malignancy in thyroid nodules: feasibility of a predictive model integrating clinical, biochemical, and ultrasound characteristics. Thyroid Res 2016; 9(4). Doi:10.1186/s13044-016-0033-y.

Details

Primary Language

English

Subjects

Endocrinology

Journal Section

Research Article

Publication Date

December 31, 2024

Submission Date

February 14, 2024

Acceptance Date

December 18, 2024

Published in Issue

Year 2024 Volume: 4 Number: 3

APA
Cetintepe, L., Cetintepe, T., Erturk, M. S., & Akinci, B. (2024). Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter. Güncel Tıbbi Araştırmaları Dergisi, 4(3), 40-47. https://doi.org/10.52818/cjmr.1436837
AMA
1.Cetintepe L, Cetintepe T, Erturk MS, Akinci B. Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter. CJMR. 2024;4(3):40-47. doi:10.52818/cjmr.1436837
Chicago
Cetintepe, Lutfi, Tugba Cetintepe, Mehmet Sercan Erturk, and Baris Akinci. 2024. “Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients With Nodular Goiter”. Güncel Tıbbi Araştırmaları Dergisi 4 (3): 40-47. https://doi.org/10.52818/cjmr.1436837.
EndNote
Cetintepe L, Cetintepe T, Erturk MS, Akinci B (December 1, 2024) Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter. Güncel Tıbbi Araştırmaları Dergisi 4 3 40–47.
IEEE
[1]L. Cetintepe, T. Cetintepe, M. S. Erturk, and B. Akinci, “Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter”, CJMR, vol. 4, no. 3, pp. 40–47, Dec. 2024, doi: 10.52818/cjmr.1436837.
ISNAD
Cetintepe, Lutfi - Cetintepe, Tugba - Erturk, Mehmet Sercan - Akinci, Baris. “Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients With Nodular Goiter”. Güncel Tıbbi Araştırmaları Dergisi 4/3 (December 1, 2024): 40-47. https://doi.org/10.52818/cjmr.1436837.
JAMA
1.Cetintepe L, Cetintepe T, Erturk MS, Akinci B. Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter. CJMR. 2024;4:40–47.
MLA
Cetintepe, Lutfi, et al. “Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients With Nodular Goiter”. Güncel Tıbbi Araştırmaları Dergisi, vol. 4, no. 3, Dec. 2024, pp. 40-47, doi:10.52818/cjmr.1436837.
Vancouver
1.Lutfi Cetintepe, Tugba Cetintepe, Mehmet Sercan Erturk, Baris Akinci. Definition of Clinical Risk Factors for Differential Thyroid Cancers in Patients with Nodular Goiter. CJMR. 2024 Dec. 1;4(3):40-7. doi:10.52818/cjmr.1436837